Published in JAMA on December 03, 2003
Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes. Kidney Int (2014) 2.22
Living donor kidney versus simultaneous pancreas-kidney transplant in type I diabetics: an analysis of the OPTN/UNOS database. Clin J Am Soc Nephrol (2009) 1.66
Current advances and travails in islet transplantation. Diabetes (2009) 1.63
Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus. J Clin Invest (2004) 1.50
Pancreatic islet transplantation. PLoS Med (2004) 1.21
Point: steady progress and current challenges in clinical islet transplantation. Diabetes Care (2009) 1.20
Transplantation for type I diabetes: comparison of vascularized whole-organ pancreas with isolated pancreatic islets. Ann Surg (2004) 1.15
Twelve-month pancreas graft function significantly influences survival following simultaneous pancreas-kidney transplantation. Clin J Am Soc Nephrol (2009) 0.99
The current state of pancreas transplantation. Nat Rev Endocrinol (2013) 0.98
SU-8-based immunoisolative microcontainer with nanoslots defined by nanoimprint lithography. J Vac Sci Technol B Microelectron Nanometer Struct Process Meas Phenom (2009) 0.97
Islet transplantation in type I diabetes mellitus. Yale J Biol Med (2012) 0.96
Pancreatic islet cell therapy for type I diabetes: understanding the effects of glucose stimulation on islets in order to produce better islets for transplantation. J Transl Med (2007) 0.94
Porcine pancreas extracellular matrix as a platform for endocrine pancreas bioengineering. Biomaterials (2013) 0.94
Islet cell transplantation today. Langenbecks Arch Surg (2007) 0.90
Improvement of pancreatic islet cell isolation for transplantation. Proc (Bayl Univ Med Cent) (2007) 0.89
Results of pancreas transplantation alone with special attention to native kidney function and proteinuria in type 1 diabetes patients. Rev Diabet Stud (2011) 0.86
Cell-based interventions to halt autoimmunity in type 1 diabetes mellitus. Clin Exp Immunol (2013) 0.84
Counterpoint: clinical islet transplantation: not ready for prime time. Diabetes Care (2009) 0.83
Accept or refuse? Factors influencing the decision-making of transplant surgeons who are offered a pancreas: results of a qualitative study. BMC Surg (2013) 0.82
Incremental value of the pancreas allograft to the survival of simultaneous pancreas-kidney transplant recipients. Diabetes Care (2009) 0.82
Current status of pancreas and islet cell transplantation. Int J Organ Transplant Med (2012) 0.81
Extracellular Matrix Scaffold Technology for Bioartificial Pancreas Engineering: State of the Art and Future Challenges. J Diabetes Sci Technol (2014) 0.81
Assessment of islet function following islet and pancreas transplantation. Curr Diab Rep (2006) 0.81
Islet transplantation as a treatment for diabetes. N Engl J Med (2004) 0.80
The role of kidney-pancreas transplantation in diabetic kidney disease. Curr Diab Rep (2010) 0.80
Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement. Transplantation (2016) 0.79
Transplantation for type 1 diabetes mellitus. Whole organ or islets? Hippokratia (2009) 0.78
Insulin-producing cells could not mimic the physiological regulation of insulin secretion performed by pancreatic beta cells. Nanoscale Res Lett (2013) 0.78
Survival after pancreas transplantation. JAMA (2005) 0.77
Isolated pancreas transplantation for type 1 diabetes: a doctor's dilemma. JAMA (2003) 0.77
Pancreatic Transplantation: Beta Cell Replacement. Curr Treat Options Gastroenterol (2004) 0.76
Pancreas transplantation. Ann R Coll Surg Engl (2008) 0.76
Is islet transplantation a realistic approach to curing diabetes? Korean J Intern Med (2017) 0.75
The time interval between kidney and pancreas transplantation and the clinical outcomes of pancreas after kidney transplantation. Clin Transplant (2011) 0.75
Transplantation of the pancreas and pancreatic islets: has it lived up to its promise? Curr Surg (2005) 0.75
Transplantation: kidney or kidney-pancreas transplant for the uremic diabetic? Nat Rev Nephrol (2009) 0.75
Pancreas transplantation: differences in activity between Europe and the United States. Nephrol Dial Transplant (2009) 0.75
Knowledge and Demand for Information about Islet Transplantation in Patients with Type 1 Diabetes. J Transplant (2011) 0.75
Predictors of non-transplantation of adult donor organs--an observational study using routine data from Eurotransplant. BMC Health Serv Res (2014) 0.75
Comparison of the effect of bone marrow cells infusion through the portal vein and inferior vena cava combined with short-term rapamycin on allogeneic islet grafts in diabetic rats. J Diabetes Investig (2016) 0.75
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med (2005) 27.77
A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med (2009) 12.15
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. N Engl J Med (2013) 11.34
Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med (2002) 8.84
Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care (2012) 7.83
Perioperative mortality and long-term survival following live kidney donation. JAMA (2010) 7.34
Diabetes and cancer: a consensus report. Diabetes Care (2010) 6.71
Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy. J Histochem Cytochem (2005) 4.40
Diabetes and cancer: a consensus report. CA Cancer J Clin (2010) 3.95
Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. Endocrinology (2003) 3.93
The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes (2006) 3.00
Translating the Diabetes Prevention Program: a comprehensive model for prevention training and program delivery. Am J Prev Med (2009) 2.88
Translating the chronic care model into the community: results from a randomized controlled trial of a multifaceted diabetes care intervention. Diabetes Care (2006) 2.59
Insulin secretion in type 1 diabetes. Diabetes (2004) 2.59
Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H). Transplantation (2003) 2.48
Influence of health care providers on the development of diabetes complications: long-term follow-up from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care (2002) 2.35
Laparoscopic live donor nephrectomy: a risk factor for delayed function and rejection in pediatric kidney recipients? A UNOS analysis. Am J Transplant (2005) 2.29
Hypotheses, design, and methods for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. Am J Cardiol (2006) 2.25
Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis. Cell Metab (2013) 2.20
Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int (2002) 2.10
Estimates of early death, acute liver failure, and long-term mortality among live liver donors. Gastroenterology (2011) 2.07
Effects of exenatide alone and in combination with daclizumab on beta-cell function in long-standing type 1 diabetes. Diabetes Care (2009) 2.02
Oligonucleotide microarray analysis of intact human pancreatic islets: identification of glucose-responsive genes and a highly regulated TGFbeta signaling pathway. Endocrinology (2002) 1.95
Increased transplanted organs from the use of a standardized donor management protocol. Am J Transplant (2002) 1.92
Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation. Transplantation (2003) 1.88
Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience. Diabetes Care (2003) 1.86
Ingestion of diet soda before a glucose load augments glucagon-like peptide-1 secretion. Diabetes Care (2009) 1.86
The relationship of fasting serum radioimmune insulin levels to incident coronary heart disease in an insulin-treated diabetic cohort. J Clin Endocrinol Metab (2004) 1.84
Evaluating the role of epigenetic histone modifications in the metabolic memory of type 1 diabetes. Diabetes (2014) 1.81
Exenatide treatment for 6 months improves insulin sensitivity in adults with type 1 diabetes. Diabetes Care (2013) 1.81
Improvements in the life expectancy of type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications study cohort. Diabetes (2012) 1.79
Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy. Lancet (2002) 1.76
Living kidney donors in need of kidney transplants: a report from the organ procurement and transplantation network. Transplantation (2002) 1.65
Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes. Diabetes (2008) 1.62
Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes. Diabetes (2010) 1.60
The rationale for the new deceased donor pancreas allocation schema. Transplantation (2007) 1.58
Lifestyle intervention is associated with lower prevalence of urinary incontinence: the Diabetes Prevention Program. Diabetes Care (2006) 1.50
Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus. J Clin Invest (2004) 1.50
High-density lipoprotein cholesterol in diabetes: is higher always better? J Clin Lipidol (2011) 1.50
Transforming growth factor-beta/Smad3 signaling regulates insulin gene transcription and pancreatic islet beta-cell function. J Biol Chem (2009) 1.49
Pulse wave analysis and cardiac autonomic neuropathy in type 1 diabetes: a report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Technol Ther (2011) 1.48
Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant (2002) 1.48
Adiponectin: good, bad, or just plain ugly? Kidney Int (2008) 1.48
Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Diabetes Care (2014) 1.47
Developing and validating a diabetes database in a large health system. Diabetes Res Clin Pract (2006) 1.46
Clinical factors associated with resistance to microvascular complications in diabetic patients of extreme disease duration: the 50-year medalist study. Diabetes Care (2007) 1.46
Aggressive pharmacologic donor management results in more transplanted organs. Transplantation (2003) 1.45
Trends over a decade of pediatric liver transplantation in the United States. Liver Transpl (2006) 1.45
Post-transplant de novo malignancies in renal transplant recipients: the past and present. Transpl Int (2006) 1.45
All-cause mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes: the Allegheny County type 1 diabetes registry. Diabetes Care (2010) 1.42
Update on cardiovascular outcomes at 30 years of the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care (2014) 1.42
Artificial sweeteners: a systematic review of metabolic effects in youth. Int J Pediatr Obes (2010) 1.41
Modifications of coronary risk factors. Am J Cardiol (2006) 1.41
Tumors, IGF-2, and hypoglycemia: insights from the clinic, the laboratory, and the historical archive. Endocr Rev (2013) 1.39
Too much glucagon, too little insulin: time course of pancreatic islet dysfunction in new-onset type 1 diabetes. Diabetes Care (2008) 1.36
Ex vivo culture with human brain endothelial cells increases the SCID-repopulating capacity of adult human bone marrow. Blood (2002) 1.33
Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Circulation (2014) 1.32
A novel approach to diabetes prevention: evaluation of the Group Lifestyle Balance program delivered via DVD. Diabetes Res Clin Pract (2010) 1.32
Sequence of progression of albuminuria and decreased GFR in persons with type 1 diabetes: a cohort study. Am J Kidney Dis (2007) 1.27
Skin intrinsic fluorescence correlates with autonomic and distal symmetrical polyneuropathy in individuals with type 1 diabetes. Diabetes Care (2011) 1.26
Liver allografts from hepatitis C positive donors can offer good outcomes in hepatitis C positive recipients: a US National Transplant Registry analysis. Transpl Int (2010) 1.25
Non-nutritive sweeteners and their role in the gastrointestinal tract. J Clin Endocrinol Metab (2012) 1.22
Early mortality rates in older kidney recipients with comorbid risk factors. Transplantation (2007) 1.22
Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity. Medicine (Baltimore) (2008) 1.22
Associations between socioeconomic status and major complications in type 1 diabetes: the Pittsburgh epidemiology of diabetes complication (EDC) Study. Ann Epidemiol (2011) 1.21
Depressive symptomatology and coronary heart disease in Type I diabetes mellitus: a study of possible mechanisms. Health Psychol (2002) 1.21
Pancreatic islet transplantation. PLoS Med (2004) 1.21
Rise of oxyntomodulin in response to oral glucose after gastric bypass surgery in patients with type 2 diabetes. J Clin Endocrinol Metab (2010) 1.20
Transplant tumor registry: donor related malignancies. Transplantation (2002) 1.19
Cardiovascular autonomic neuropathy, HDL cholesterol, and smoking correlate with arterial stiffness markers determined 18 years later in type 1 diabetes. Diabetes Care (2009) 1.18
Effectiveness and cost-effectiveness of diabetes prevention among adherent participants. Am J Manag Care (2013) 1.18
Hormonal resuscitation yields more transplanted hearts, with improved early function. Transplantation (2003) 1.18
Haptoglobin genotype and renal function decline in type 1 diabetes. Diabetes (2009) 1.18
Interacting epidemics? Sleep curtailment, insulin resistance, and obesity. Ann N Y Acad Sci (2012) 1.15
Minocycline-induced drug hypersensitivity syndrome followed by multiple autoimmune sequelae. Arch Dermatol (2009) 1.15
Assessment of pancreatic islet mass after islet transplantation using in vivo bioluminescence imaging. Transplantation (2005) 1.15
Effects of diet soda on gut hormones in youths with diabetes. Diabetes Care (2012) 1.15
Middle-aged premenopausal women with type 1 diabetes have lower bone mineral density and calcaneal quantitative ultrasound than nondiabetic women. Diabetes Care (2006) 1.13
Transcriptional analysis of intracytoplasmically stained, FACS-purified cells by high-throughput, quantitative nuclease protection. Nat Biotechnol (2009) 1.13
Blood glucose levels regulate pancreatic beta-cell proliferation during experimentally-induced and spontaneous autoimmune diabetes in mice. PLoS One (2009) 1.11
Evening chronotype is associated with changes in eating behavior, more sleep apnea, and increased stress hormones in short sleeping obese individuals. PLoS One (2013) 1.11
The design and rationale of the saxagliptin assessment of vascular outcomes recorded in patients with diabetes mellitus-thrombolysis in myocardial infarction (SAVOR-TIMI) 53 study. Am Heart J (2011) 1.11
Impact of the expanded criteria donor allocation system on the use of expanded criteria donor kidneys. Transplantation (2005) 1.10
Analysis of the wait list and deaths among candidates waiting for a kidney transplant. Transplantation (2008) 1.10
Increased insulin translation from an insulin splice-variant overexpressed in diabetes, obesity, and insulin resistance. Mol Endocrinol (2004) 1.10
Dynamic changes in pancreatic endocrine cell abundance, distribution, and function in antigen-induced and spontaneous autoimmune diabetes. Diabetes (2009) 1.10
Artificial sweetener use among children: epidemiology, recommendations, metabolic outcomes, and future directions. Pediatr Clin North Am (2011) 1.09
Markers of endothelial dysfunction in the prediction of coronary artery disease in type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study. J Diabetes Complications (2005) 1.09